After being outbid in two high-profile deals over the past six months, Sanofi (ENXTPA:SAN) is now examining an acquisition of Tesaro, Inc. (NasdaqGS:TSRO), according to a person claiming to have knowledge of the matter. Morgan Stanley is said to be advising on the potential takeover.